Skip to main content
. 2024 Jul 16;20(24):1753–1764. doi: 10.1080/14796694.2024.2370186

Figure 1.

Figure 1.

Study design.

EGFR: Epidermal growth factor receptor; TKI: Tyrosine kinase inhibitor.

HHS Vulnerability Disclosure